2025 ESC/EACTS Guidelines for the management of valvular heart disease.
Fabien Praz, Michael A Borger, Jonas Lanz...
https://pubmed.ncbi.nlm.nih.gov/40878295/Actively Recruiting
Led by Yan'an Affiliated Hospital of Kunming Medical University · Updated on 2026-04-16
300
Participants Needed
1
Research Sites
N/A
Total Duration
Severe aortic stenosis AS often occurs alongside coronary artery disease CAD, complicating treatment decisions before aortic valve replacement AVR. Researchers are evaluating whether adding a functional heart blood flow test called CT-derived fractional flow reserve CT-FFR to the usual coronary computed tomography angiography CCTA can better guide treatment and improve patient outcomes. This randomized controlled trial includes 300 patients with severe AS scheduled for transcatheter or surgical AVR to compare these two approaches. Participants are randomly assigned to one of two groups one group will have their preoperative revascularization decisions guided by both CCTA anatomical information and CT-FFR functional data, while the other group will have decisions based on CCTA alone. The study uses CT-FFR to identify significant ischemia and helps the Heart Team plan revascularization strategies such as PCI or CABG accordingly. Both groups receive standard AVR treatment, and the follow-up period lasts one year after the procedure. During the study, patients undergo preoperative coronary imaging and assessments to guide treatment planning. Researchers will track major adverse cardiovascular events MACE over 365 days post-AVR, including heart attacks, unstable angina, cardiac death, strokes, revascularizations, valve interventions, and serious bleeding. Secondary outcomes include mortality and composite endpoints at 30 days and one year. This trial aims to see if combining CT-FFR with CCTA can optimize treatment decisions and reduce post-surgery complications.
CONDITIONS
CLEAR-AS: CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis
X
Xirui Duan
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Yan'an Affiliated Hospital of Kunming Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 month before AVR
Participants undergo coronary computed tomography angiography (CCTA) with or without CT-derived fractional flow reserve (CT-FFR) to guide revascularization decisions prior to aortic valve replacement (AVR). This evaluation helps determine the need for concomitant or staged coronary interventions.
1 to 2 visits depending on assigned group
Duration - 1 day
Participants receive transcatheter or surgical aortic valve replacement based on preoperative planning.
1 in-person procedure visit
Duration - 365 days
Participants are followed for 365 days after AVR to monitor major adverse cardiovascular events and other clinical outcomes.
Regular follow-up visits during 1 year post-AVR
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Fabien Praz, Michael A Borger, Jonas Lanz...
https://pubmed.ncbi.nlm.nih.gov/40878295/Writing Committee Members, Catherine M Otto, Rick A Nishimura...
https://pubmed.ncbi.nlm.nih.gov/33342587/Ricardo C Cury, Jonathon Leipsic, Suhny Abbara...
https://pubmed.ncbi.nlm.nih.gov/36436841/Yan'an Affiliated Hospital of Kunming Medical University
Lead Sponsor